KaloBios Pharmaceuticals Garners $17,000,000 New Financing Round

  • Feed Type
  • Date
    5/22/2012
  • Company Name
    KaloBios Pharmaceuticals
  • Mailing Address
    260 East Grand Avenue South San Francisco, CA 94080
  • Company Description
    KaloBios is a vertically integrated therapeutic antibody company using its proprietary antibody engineering, humaneering and expression technologies for the development of a pipeline of antibody therapeutics.
  • Website
    http://www.kalobios.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $17,000,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing.
  • M&A Terms
  • Venture Investor
    Undisclosed

By posting a comment, you agree to our terms and conditions.